Fiduciary Trust’s Soligenix SNGX Stock Holding History

Fiduciary Trust’s Portfolio SNGX Stock Details SNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-170	Closed	-$18.4K	–	630
2022 Q4	$18.4K	Hold	170	–	–	﹤0.01%	622
2022 Q3	$18K	Buy	+170	New	+$29.8K	﹤0.01%	607

Other funds holding SNGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PMFA

Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fiduciary Trust's SNGX Position: Q1 2023 in Review

Fiduciary Trust sold out of Soligenix (SNGX) in Q1 2023, closing a stake of 170 shares — an estimated $18.4K sold.

Fiduciary Trust first reported a position in SNGX in Q3 2022 and held it in 2 quarters. The position peaked at $18.4K in Q4 2022. 14 funds tracked by Wall St. Rank hold SNGX as of Q1 2023.

Fiduciary Trust reported no remaining Soligenix position as of Q1 2023 after selling out during the quarter.
Fiduciary Trust sold 170 Soligenix shares in Q1 2023, an estimated $18.4K.
Fiduciary Trust first reported a position in Soligenix in Q3 2022 and held it in 2 quarters.
Fiduciary Trust's Soligenix position peaked at $18.4K in Q4 2022.
14 funds tracked by Wall St. Rank held Soligenix as of Q1 2023.

Based on Fiduciary Trust's 13F filing for Q1 2023, filed 15 May 2023.